Stock OIL OPTISCAN IMAGING LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Optiscan Imaging Limited

Equities

OIL

AU000000OIL4

Advanced Medical Equipment & Technology

Market Closed - Australian S.E.
Other stock markets
 02:10:47 2024-04-30 am EDT 		5-day change 1st Jan Change
0.089 AUD +4.71% Intraday chart for Optiscan Imaging Limited +8.54% +5.95%
Mar. 21 Optiscan Imaging Receives More Than AU$670,000 as R&D Tax Rebate MT
Feb. 22 Optiscan Imaging Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 28.12 27.27 17.68 141.7 68.13 50.1
Enterprise Value (EV) 1 26.56 25.72 18.31 134 64.15 49.64
P/E ratio -13.3 x -10.7 x -9.94 x -61.8 x -16.1 x -11.4 x
Yield - - - - - -
Capitalization / Revenue 12.9 x 20.6 x 9.34 x 63 x 30.3 x 19.1 x
EV / Revenue 12.2 x 19.5 x 9.67 x 59.6 x 28.5 x 19 x
EV / EBITDA -9.85 x -12.3 x -11.3 x -58.8 x -15.5 x -12 x
EV / FCF -11 x -56.3 x -21.6 x -83.3 x -26.6 x -27 x
FCF Yield -9.08% -1.78% -4.64% -1.2% -3.77% -3.71%
Price to Book 8.78 x 9.66 x 11.4 x 13.9 x 10.3 x 16.5 x
Nbr of stocks (in thousands) 432,679 470,179 477,779 616,261 619,406 626,306
Reference price 2 0.0650 0.0580 0.0370 0.2300 0.1100 0.0800
Announcement Date 8/31/18 8/30/19 8/31/20 8/29/21 8/31/22 8/30/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 2.186 1.322 1.893 2.249 2.249 2.618
EBITDA 1 -2.698 -2.097 -1.615 -2.277 -4.144 -4.133
EBIT 1 -2.787 -2.219 -1.705 -2.363 -4.232 -4.35
Operating Margin -127.5% -167.83% -90.05% -105.08% -188.17% -166.18%
Earnings before Tax (EBT) 1 -2.035 -2.344 -1.765 -2.127 -4.233 -4.352
Net income 1 -2.035 -2.344 -1.765 -2.127 -4.233 -4.352
Net margin -93.13% -177.3% -93.25% -94.57% -188.22% -166.22%
EPS 2 -0.004905 -0.005404 -0.003721 -0.003721 -0.006844 -0.007000
Free Cash Flow 1 -2.412 -0.4566 -0.8492 -1.608 -2.416 -1.841
FCF margin -110.37% -34.54% -44.86% -71.52% -107.41% -70.31%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 8/31/18 8/30/19 8/31/20 8/29/21 8/31/22 8/30/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 0.63 - - -
Net Cash position 1 1.56 1.55 - 7.77 3.98 0.46
Leverage (Debt/EBITDA) - - -0.3899 x - - -
Free Cash Flow 1 -2.41 -0.46 -0.85 -1.61 -2.42 -1.84
ROE (net income / shareholders' equity) -83.6% -77.8% -80.8% -36.2% -50.4% -90.3%
ROA (Net income/ Total Assets) -51.2% -35.7% -30.1% -19.5% -26.9% -43%
Assets 1 3.972 6.571 5.873 10.9 15.75 10.13
Book Value Per Share 2 0.0100 0.0100 0 0.0200 0.0100 0
Cash Flow per Share 2 0 0 0 0.0100 0.0100 0
Capex 1 0.29 0 0.02 0.03 0.12 0.13
Capex / Sales 13.29% 0.34% 1.07% 1.37% 5.52% 4.85%
Announcement Date 8/31/18 8/30/19 8/31/20 8/29/21 8/31/22 8/30/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
OPTISCAN IMAGING LIMITED Stock Optiscan Imaging Limited
+5.95% 46.58M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.83% 220B
DANAHER CORPORATION Stock Danaher Corporation
+6.21% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+9.80% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+24.39% 107B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.95% 63.05B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+11.92% 51.74B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.47B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.24% 40.91B
RESMED, INC. Stock ResMed, Inc.
+23.27% 31.91B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. OIL Stock
  4. Financials Optiscan Imaging Limited